FI
Fosun International Portfolio holdings
AUM
$360M
This Quarter Return
+12.61%
1 Year Return
+38.28%
3 Year Return
+3.77%
5 Year Return
+27.59%
10 Year Return
+94.55%
AUM
$1.57B
AUM Growth
-$99.9M
(-6%)
Cap. Flow
-$265M
Cap. Flow
% of AUM
-16.83%
Top 10 Holdings %
Top 10 Hldgs %
52.85%
Holding
343
New
45
Increased
88
Reduced
68
Closed
37
Top Buys
| 1 |
BZUN
Baozun
BZUN
|
$20.3M |
| 2 |
MOMO
Hello Group
MOMO
|
$6.36M |
| 3 |
Bristol-Myers Squibb
BMY
|
$3.97M |
| 4 |
BBU
Brookfield Business Partners
BBU
|
$3.38M |
| 5 |
Neurocrine Biosciences
NBIX
|
$3.34M |
Top Sells
| 1 |
KANG
iKang Healthcare Group, Inc.
KANG
|
$94.3M |
| 2 |
Vipshop
VIPS
|
$53.6M |
| 3 |
DigitalBridge
DBRG
|
$37.5M |
| 4 |
Brookdale Senior Living
BKD
|
$33.9M |
| 5 |
Criteo
CRTO
|
$15.3M |
Sector Composition
| 1 | Healthcare | 37.62% |
| 2 | Financials | 6.46% |
| 3 | Consumer Discretionary | 4.13% |
| 4 | Industrials | 2.9% |
| 5 | Communication Services | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Norfolk Southern
NSC
$62.6B
| $949K | 0.06% |
5,090
+3,490
| +218% | +$651K |
|
152
Albemarle
ALB
$9.24B
| $942K | 0.06% |
11,600
+500
| +5% | +$40.6K |
|
|
MTEM
153
DELISTED
Molecular Templates, Inc.
MTEM
| $940K | 0.06% |
10,866
+3,064
| +39% | +$265K |
|
154
Cartesian Therapeutics
RNAC
$261M
| $938K | 0.06% |
14,611
+8,844
| +153% | +$568K |
|
155
McKesson
MCK
$86.3B
| $935K | 0.06% |
7,985
-3,100
| -28% | -$363K |
|
156
Liberty Global Class A
LBTYA
$4.07B
| $934K | 0.06% |
+37,000
| New | +$934K |
|
157
Workday
WDAY
$60.8B
| $932K | 0.06% |
+4,900
| New | +$932K |
|
158
AT&T
T
$211B
| $915K | 0.06% |
39,058
| – | – |
|
159
T-Mobile US
TMUS
$287B
| $899K | 0.06% |
13,000
| – | – |
|
160
Quanta Services
PWR
$55.6B
| $890K | 0.06% |
+23,800
| New | +$890K |
|
161
Hormel Foods
HRL
$13.8B
| $888K | 0.06% |
+20,000
| New | +$888K |
|
162
Rhythm Pharmaceuticals
RYTM
$6.84B
| $887K | 0.06% |
29,720
| – | – |
|
163
NOV
NOV
$4.81B
| $875K | 0.06% |
33,000
| – | – |
|
164
Becton Dickinson
BDX
$54.3B
| $872K | 0.06% |
3,618
-308
| -8% | -$74.2K |
|
|
VIRX
165
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $863K | 0.05% |
+20,714
| New | +$863K |
|
166
IBM
IBM
$227B
| $828K | 0.05% |
6,187
| – | – |
|
167
Estee Lauder
EL
$32.1B
| $824K | 0.05% |
5,010
+300
| +6% | +$49.3K |
|
168
Intuit
INTU
$184B
| $815K | 0.05% |
3,145
| – | – |
|
169
Charles Schwab
SCHW
$176B
| $811K | 0.05% |
19,000
| – | – |
|
170
Agilent Technologies
A
$35.4B
| $810K | 0.05% |
10,160
| – | – |
|
171
Pfizer
PFE
$140B
| $787K | 0.05% |
19,604
-52,209
| -73% | -$2.1M |
|
|
INFI
172
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $786K | 0.05% |
418,296
+40,000
| +11% | +$75.2K |
|
173
Oracle
ORCL
$620B
| $779K | 0.05% |
14,655
| – | – |
|
174
Cidara Therapeutics
CDTX
$1.6B
| $773K | 0.05% |
15,334
| – | – |
|
175
Goldman Sachs
GS
$223B
| $765K | 0.05% |
4,000
-2,915
| -42% | -$557K |
|